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1. Introduction and question 
 
The membrane potential of pulmonary vascular smooth muscle cells is a key regulator 
of the arterial tone. These cells have a resting membrane potential of approximately -65 
to -50 mV in vitro, close to the predicted equilibrium potential for potassium (K+) ions. 
Thereby, the vasodilator effect of agents that induces the K+ channels opening in the 
pulmonary arterial smooth muscle cell (PASMC) membrane increases the K+ efflux, 
which in turn results in membrane hyperpolarization. Due to this hyperpolarization, the  
voltage-dependent Ca2+ channels are closed, which decreases the Ca2+ entry and leads 
to vasodilatation (Clapp et al., 1993), (Wanstall, 1996). Conversely, the vasoconstrictor 
action of drugs inhibits K+ channels causing membrane depolarization, Ca2+ entry, cell 
contraction, and finally vasoconstriction (Hara et al., 1980),(Hasunuma et al., 
1991),(Post et al., 1992). 
Background or leak K+-selective channels, as defined by a lack of time and voltage 
dependency, play an essential role in setting the resting membrane potential and input 
resistance in excitable cells. These channels are structurally unique in that each subunit 
possesses four transmembrane segments and two pore-forming domains and hence 
are often referred to as two-pore domain K+ channels. Two-pore domain K+ (2-PK) 
channels have been shown to conduct several leak K+ currents. The activity of 2-PK 
channels is strongly regulated by numerous chemical and physical physiological stimuli, 
such as extracelluar pH, protons, protein kinases, phospholipids, neurotransmitters, 
volatile anesthetics and hypoxia (Gurney et al., 2009). An alteration of the K+ 
conductance can influence the cellular activity via membrane potential changes. 
Both, RT-PCR and Northern blot analyses using mammalian lung tissue have identified 
mRNA transcripts for several 2-PK channels (Medhurst et al., 2001),(Duprat et al., 
1997),(Lesage et al., 2000). Recently, TASK-1 (TWIK-related acid-sensitive K+ ;TWIK, 
for tandem P domains in a weak inwardly rectifying K+), a member of the 2-PK channel 
family has been described in rabbit PASMC (Gurney et al., 2003) as well as in rat 
pulmonary arteries (Gardener et al., 2004). This channel produces K+ currents that 
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possess all of the characteristics of background conductances. The activity of TASK-1 is 
strongly dependent on the external pH and oxygen tension, suggesting that this 
particular channel might be a sensor of external pH variations and of hypoxia in 
pulmonary arteries. 
The present report demonstrates the expression of TASK-1 in human PASMC. Our 
study has tested the hypothesis that TASK-1 contributes to the K+ current and resting 
membrane potential by using TASK-1 small interfering RNA (siRNA). Moreover, we 
show that TASK-1 is reversibly inhibited by acute hypoxia, which is compatible with it 
being responsible for the oxygen sensitivity of the membrane potential. 
Endothelin-1 (ET-1), a 21-amino-acid peptide secreted by vascular endothelial cells, is 
the most potent vasoconstrictor described to date (Yanagisawa et al., 1988) and is 
considered to be a major player within the pathological mechanisms involved in 
pulmonary arterial hypertension (PAH) (Stewart et al., 1991),(Giaid et al., 1993). ET-1 
causes long-lasting vasoconstriction(Yanagisawa et al., 1988) and excessive 
proliferation in pulmonary artery smooth muscle cells (Hirata et al., 1989),(Wort et al., 
2001),(Davie et al., 2002), contributing to vascular remodeling. Multiple lines of 
evidences show that ET-1 plays a central role in the pathogenesis of pulmonary arterial 
hypertension (PAH) (Hynynen et al., 2006),(Galie et al., 2004),(Galie et al., 2004),(Giaid 
et al., 1993),(Rubin et al., 2002),(Chen et al., 1995). K+ channels determine the 
membrane potential of PASMCs and represent an important controller of their calcium 
homeostasis (Yuan, 1995),(Olschewski et al., 2002). Furthermore, it is now well 
established that an inhibition of K+ channels e.g. by serotonin or hypoxia causes 
membrane depolarization and stimulates PASMC proliferation (Weir et al., 2006),(Yu et 
al., 2001),(Eddahibi et al., 2006). Several reports indicate that TASK-1 plays an 
important role in human pulmonary circulation. The TASK-1 channel contributes 
substantially to the K+ conductance and sets resting membrane potential in PASMCs 
(Gurney et al., 2003),(Gardener et al., 2004), where other K+ channels like 
voltage-gated (KV) or calcium-dependent K+ channels are not activated. Moreover, 
TASK-1 is modulated by extracelluar pH, protein kinases, hypoxia or vasoactive factors 
such as prostacyclin (Duprat et al., 1997),(Buckler et al., 2000). Furthermore, the 
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two-pore K+ domain channels are supposed to be involved in hypoxic pulmonary 
vasoconstriction (Gurney et al., 2006). 
Based on their properties, both TASK-1 channels and ET-1 might interact in the 
pathogenesis of PAH. Although numerous studies have investigated ion channels in 
PAH, the TASK-1 in human PASMC has not been taken into account until now. 
Considering the features of TASK-1, we have hypothesized that ET-1 might inhibit 
TASK-1 channels. In particular, to date, the molecular signaling mechanism for inhibition 
of TASK-1 in native human cells is poorly understood. Therefore, in the present study, 
we have investigated the signaling pathway and the effects of ET-1 on TASK-1 in 
primary human PASMCs and found the pathway from ETA receptors, through 
phospholipase C (PLC), phosphatidylinositol 4,5-biphosphate (PIP2), diacylglycerol 
(DAG) and protein kinase C (PKC) to TASK-1. 
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2. Potassium channels in human PASMCs 
 
The potassium current in PASMCs is an ensemble, reflecting activity of many different 
channels. At least three classes of potassium channels have been identified in PASMCs: 
voltage-dependent potassium channels (Kv) (Yuan, 1995),(Post et al., 1995),(Evans et 
al., 1996), calcium-activated potassium channels (KCa) (Albarwani et al., 1994),(Peng et 
al., 1999) and ATP-sensitive potassium channels (KATP) (Nelson et al., 1995). The 
potassium channels which control the resting membrane potential (Em) in PASMCs, and 
inhibition of which initiates hypoxic pulmonary vasoconstriction (HPV), conduct an 
outward current which is slowly inactivated and blocked by the Kv channel blocker 
4-aminopyridine (4-AP) but not by inhibitors of KCa or KATP, at least in the rat (Yuan, 
1995),(Archer et al., 1996),(Archer et al., 1998). At the molecular level, Kv channels are 
homo- or heteromultimeric tetramers composed of two structural distinct subunits: the 
pore forming α-subunits and the regulatory β-subunits (Hille, 1986). Nine families of Kv 
channel α-subunits are recognized from cloning studies (Kv1-9) (Hille, 1986),(Pongs, 
1992), each with subtypes (e.g. Kv1.1-1.6). The molecular identification of the specific 
Kv channels that control Em is difficult, even with advanced electrophysiological 
techniques, mainly due to lack of specific blockers. However, the intracellular dialysis of 
specific Kv antibodies combined with patch-clamp recordings, studies in expression 
systems, or the use of reverse transcription polymerase chain reaction (PCR) may throw 
light on the involvement of K+ channels in the mechanism of HPV. The potential 
candidate Kv channel α-subunits that could form O2-sensitive channels in PA SMCs are 
Kv1.2 (Wang et al., 1997),(Hulme et al., 1999) , Kv1.5 (Archer et al., 1998),(Wang et al., 
1997), Kv2.1 (Archer et al., 1998),(Hulme et al., 1999),(Patel et al., 1997), Kv3.1 
(Osipenko et al., 1997) and Kv9.3 (Hulme et al., 1999),(Patel et al., 1997).
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3. Background two-pore domain potassium channels (K2P) 
 
Background or leak K+-selective channels, as defined by a lack of time and voltage 
dependency, play an essential role in setting the resting membrane potential and input 
resistance in excitable cells. Alteration of the K+ conductance in these cells influences 
the cellular activity via membrane potential changes. Two-pore domain K+ (K2P) 
channels have been shown to conduct several leak K+ currents. This new gene family of 
K+ channels has been progressively identified over the last few years (Bayliss et al., 
2001). Members of the KCNK family present structural features that suggest a dimeric 
arrangement, with each subunit comprising four transmembrane segments and two 
pore-forming regions (Fig. 1A). The channels formed by members of this family are 
distinct from voltage-dependent or inwardly rectifying K+ channels in so far as most are 
constitutively active at resting membrane potentials and generate currents that rectify 
only very weakly. They can be grouped into six subfamilies based on their structural and 
functional properties in mammals: the TWIK (TWIK1, TWIK2, KCNK7), TASK (TASK1, 
TASK3, TASK5), TREK (TREK1, TREK2, TRAAK), TALK (TALK1, TALK2, TASK2), 
THIK (THIK1, THIK2) and TRESK subfamilies (Goldstein et al., 1998),(O'Connell et al., 
2002).  
K2P channels are found in neuronal and non-neuronal tissues providing a wide variety of 
important functions, including the sensing of oxygen and pH (Patel et al., 2001), the 
setting of resting membrane potentials (Kim et al., 1998),(Millar et al., 2000), the sensing 
of changes in [K+], the responses to agonists (Kim, 2003), neuroprotection (Buckler et 
al., 2005) and mechanosensitivity (Kim, 2003),(Chemin et al., 2005). K2P channels are 
also candidates for the action of volatile anesthetics on neural excitability (Buckingham 
et al., 2005). Most detailed information about the function of these channels comes from 
studies on cloned channels heterologously expressed in model cells. 
TASK-1 and TASK-3, along with the silent subunit TASK-5, form a distinct structural and 
functional subgroup. The TASK-1 amino acid sequence shares 54% identity with 
TASK-3. The heteromultimerization between both subunits has been demonstrated 
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(Kang et al., 2004),(Czirjak et al., 2002). TASK-1 is a two-pore domain K+ channel that 
generates a pH-sensitive, weakly-rectifying K+ current (Duprat et al., 
1997),(Leonoudakis et al., 1998),(Kim et al., 1998). TASK-1 is called an ‘open rectifier’ 
because it exhibits no time-dependence and/or extremely fast kinetics (Lopes et al., 
2000). The current-to-voltage relationship of TASK channels becomes linear in a 
symmetrical K+ gradient (reversing at 0 mV). This typical channel behavior is expected 
of a K+-selective leak channel, as predicted by the Goldman-Hodgkin-Katz formulation 
(open rectifier). The homomultimers TASK-1, TASK-3 and the heteromultimer 
TASK-1–TASK-3 have single-channel conductances (determined in a symmetrical K+ 
gradient) of 14 pS, 37 pS and 38 pS, respectively and are characterized by a typical 
flickery gating (Czirjak et al., 2002),(Han et al., 2002). 
Several studies have inferred that K2P channels may be involved in important cerebellar 
functions, such as spatial determination and accuracy, motor coordination, balance, 
muscle tone, and learning of motor skills. In other regions of the brain, K2P channels, 
such as TASK-1 and TASK-3, are expressed and may function in behavior such as 
sleep and wakefulness, contribute to background conductance, and provide acid and 
volatile anesthetics sensitivity (Meuth et al., 2003). In contrast, there have been limited 
reports of K2P channels in cardiac or smooth muscle tissues. Due to TASK-1 cardiac 
myocytes display a background K+ current, (Kim et al., 1998), influencing the amplitude 
and duration of action potentials (Backx et al., 1993). Smooth muscle cells in the carotid 
body express TASK-3. Another group has reported expression of TASK and TREK 
isoforms in human myometrium using RT-PCR.  Western analyses have showed the 
expression of TASK-1 and TREK-1 in this tissue (Bai et al., 2005). Subsequently, 
Sanders & Koh have found expression and function of TASK and TREK channels in 
gastrointestinal smooth muscle cells (Sanders et al., 2006). Their findings support the 
role of TASK-1 in the regulation of gastrointestinal smooth muscles. In addition, TASK-1 
channels appear to participate in establishing the moment-to-moment state of 
excitability in gastrointestinal muscles. Finally, there exist an evidence that TASK-1 
maintains the resting potential in bladder smooth muscles (Beckett et al., 2008). The 
relevance of TASK-1 in vascular smooth muscle cells with special focus on the 
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pulmonary arteries is described in the next section. 
 
Fig. 1: Topology and pharmacology of K2P channels. (from Patel et al., 2004) 
A: 2P-domain K+ channels consist of four transmembrane segments and two pores in 
tandem, P1 and P2. A functional channel is a dimer of subunits. B: TASK-1/3 channels 
are inhibited by extracellular acidosis.
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4. TASK-1 channels in PASMCs 
 
Macroscopic currents that occur due to TASK-1 channels display kinetics and 
voltage-dependent properties very similar to TASK-3 (i.e. TASK-3 is also an open 
rectifier) (Kim et al., 2000),(Rajan et al., 2000), but the two channels can be 
distinguished by the pH range over which their activity is modulated (Fig. 1B). The pK of 
TASK-1 channels is 7.4, squarely in the physiological range, whereas the pK for TASK-3 
channels is shifted to a more acidic level (6.7) (Duprat et al., 1997),(Leonoudakis et al., 
1998),(Kim et al., 1998),(Rajan et al., 2000). The TASK-2 channel sequence shares less 
homology with the other TASK channels and generates outwardly rectifying pH-sensitive 
currents with a pK of 8.4 (Reyes et al., 1998).  
Gurney and colleagues have recently shown the TASK-1 expression in smooth muscle 
cells of the pulmonary artery in a rabbit (Gurney et al., 2003). The authors have also 
demonstrated functional expression of a conductance in these cells that is inhibited by 
extracellular pH, Zn2+ and by the endocannabinoid anandamide, but the conductance is 
insensitive to intracellular Ca2+, 4-aminopyridine and quinine. In addition, the 
non-inactivating K+ current is facilitated by halothane causing hyperpolarization of 
PASMC. These properties closely mimic the pharmacology of heterologously-expressed 
TASK-1 channels. In order to investigate the expression of TASK channels in human 
pulmonary arteries we have developed the preparation of primary human pulmonary 
artery smooth muscle cells. In this study, we demonstrate the expression of TASK-1 
mRNAs and proteins in human pulmonary artery smooth muscle cells through the 
simultaneous absence of TASK-2 and TASK-3 expression (Fig. 6). In addition, we have 
found an anandamide-sensitive conductance in both primary and cultured human 
pulmonary artery smooth muscle cells that have properties similar to TASK-1 channels. 
The native conductance showes an outward rectification in low external K+ solution, is 
instantaneous and noninactivating, activated by alkalotic pH, and blocked by 
anandamide. Transfection of TASK-1 siRNA into human pulmonary artery smooth 
muscle cells significantly depolarizes the resting membrane potential and abolishes the 
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effect of pH or anandamide. Respectively, we concluded that TASK-1 channels are 
responsible for the pH-sensitive, voltage-independent background conductance that sets 
the resting membrane potential in human pulmonary artery smooth muscle.
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5. Role of endothelin-1 in pulmonary hypertension (PH) 
 
Endothelin-1 (ET-1), which is a 21-amino acid peptide that is secreted in the vascular 
endothelial cells, causes potent and persistent vasoconstriction (Yanagisawa et al., 
1988) in vascular tissues. It is important to understand the mechanisms by which ET-1 
causes a constriction in the human pulmonary vasculature, since a growing body of 
evidence implicates ET-1 as an important modulator of the pulmonary vascular tone and 
suggests ET-1 to be involved in the pathogenesis of pulmonary hypertension. For 
example, multiple lines of evidences show that ET-1 plays a central role in the 
pathogenesis of PAH (Hynynen et al., 2006). First, ET-1 is an effective pulmonary 
vasoconstrictor and induces vascular smooth muscle hyperplasia (Galie et al., 2004). 
Second, plasma levels of ET-1 are increased in patients with primary and secondary 
pulmonary hypertension (Galie et al., 2004). Moreover, ET-1 overexpression is 
associated with PAH (Giaid et al., 1993). Finally, specific pharmacological inhibition of 
ET-1 receptors attenuates the development of PH (Rubin et al., 2002),(Chen et al., 1995) 
and prolongs the survival in animal models of PH. 
ET-1 has been shown to affect several different types of ion channel in vascular smooth 
muscles. Various signaling pathways have been implicated in these effects. The binding 
of ET-1 to G protein–coupled ETA receptors activates the PLC cascade, thereby 
initiating the conversion of phosphoinositol to inositol trisphosphate (IP3) and 
1,2-diacylglycerol (DAG), which activates PKC. Once activated, PKC exerts a number of 
significant effects on vascular smooth muscle cells, including the stimulation of cell 
proliferation (Zamora et al., 1993) and the modulation of ion channels. Studies have 
revealed that ET-1 activates receptor-operated Ca2+ (Goto et al., 1989),(Inoue et al., 
1990), Cl- (Van Renterghem et al., 1993) and nonselective cation channels (Nakajima et 
al., 1996),(Oonuma et al., 2000). ET-1 inhibits KATP channels and KV channels in 
coronary and pulmonary arteries, respectively (Miyoshi et al., 1992),(Shimoda et al., 
1998),(Shimoda et al., 2001)  In addition, Peng et al. (Peng et al., 1998) have 
demonstrated a dual effect of ET-1 on KCa currents in cultured human PASMCs, with 
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ET-1 activating KCa current at low concentrations and inhibiting KCa current at high 
concentrations. Our study demonstrates that ET-1 modulates TASK-1 via the PKC 
signaling pathway in primary human pulmonary arterial smooth muscle cells.
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6. Materials and Methods 
 
6.1 Patch-clamp technique 
Erwin Neher and Bert Sakmann developed the patch clamp in the late 1970s (Neher et 
al., 1976) and early 1980s (Hamill et al., 1981). This discovery made it possible to 
record the currents of single ion channels for the first time, proving their involvement in 
fundamental cell processes such as action potential conduction. Neher and Sakmann 
received the Nobel Prize in Physiology or Medicine in 1991 for their work (Neher, 1992). 
 
6.1.1 Patch clamp 
One of the advantages of the patch clamp technique was that it allowed measurements 
on very small cells such as mammalian cells. The technique can be applied to a wide 
variety of cells, but was especially useful in the study of excitable cells such as neurons, 
cardiomyocytes, muscle fibers and pancreatic beta cells. Figure as shown below, the 
basic principle of this technique was that a fluid filled micropipette containing a 
silver/silver chloride electrode was brought into contact with the cell membrane. The 
interior of the pipette was filled with a solution matching the ionic composition of the bath 
solution. A chlorided silver wire was placed in contact with this solution and conducts 
electrical current to the amplifier. By applying gentle suction to the pipette, a giga-seal 
was formed between the pipette and the cell membrane. The high resistance of this seal 
made it possible to electronically isolate the currents measured across the membrane 
patch with little competing noise, as well as providing some mechanical stability to the 
recording. Further suction can rupture the patch of membrane under the tip of the 
micropipette, providing access for the microelectrode to the interior of the cell; this 
situation was termed as the whole cell configuration. The whole cell configuration 
allowed the summed activity of all of the ion channels in the cell membrane (the 
whole-cell current or macroscopic current) to be measured simultaneously. The 
investigator can change the composition of this solution or add drugs to study the ion 
channels under different conditions. 
CHAPTER 6            MATERIALS AND METHODS             PAGE 15
 
 
 
 
Fig 2: The principle of the whole cell patch-clamp technique (from the online media: 
http://media.wiley.com/CurrentProtocols/PH/ph1008/ph1008-fig-0002-1-full.gif). 
 
 
6.1.2 Voltage clamp 
The voltage clamp technique allowed the membrane potential of a cell to be clamped at 
a constant value. The current that flowed through the membrane at any particular 
potential can be measured. The principle of the technique was to inject a current which 
was equal in amplitude but opposite in sign to the current flowing across the cell. This 
results in no net current flowed across the membrane, and the membrane potential 
remained constant. Therefore, by measuring the current, which had to be injected to 
clamp the potential, the current flowing across the membrane can be determined. By 
measuring currents at different clamped membrane potentials it was possible to 
characterize voltage-gated ion channels. 
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The principle of this technique is depicted below. The membrane potential amplifier 
measures membrane voltage and send output to the feedback amplifier. The feedback 
amplifier subtracts the membrane voltage from the command voltage, which it received 
from the signal generator. This signal is amplified and returned into the cell via the 
recording electrode. 
 
 
 
 
 
 
Fig 3: The voltage clamp used a negative feedback mechanism (from the online 
media: http://wpcontent.answers.com/wikipedia/en/e/ea/Voltage_clamp.jpg). 
 
 
6.1.3 Current clamp 
The basic principle of current clamp is the same as voltage clamp, the only difference is 
that here current was clamped instead of the voltage. The current clamp technique was 
used to measure the membrane potential such as the action potential of an excitable 
cell by injecting current into a cell to keep electrical current constant through the 
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recording electrode. It can be used for both extracellular and intracellular recordings. 
Unlike in the voltage clamp mode, where the membrane potential was held at a level 
determined by the experimenter, in "current clamp" mode the membrane potential was 
free to vary, and the amplifier recorded whatever voltage the cell generated on its own 
or as a result of stimulation. This technique was used to study how a cell responds when 
electric current enters a cell. This was important for instance for understanding how 
neurons or other excitable cells respond to neurotransmitters and chemical substance 
that act by opening membrane ion channels. 
 
6.2 Electrophysiology in the present study 
 
The whole-cell patch-clamp technique on hPASMC was used, as previously described, 
to measure the resting membrane potential under current clamp and macroscopic K+ 
currents under voltage clamp (Gurney et al., 2003),(Osipenko et al., 1997),(Hong et al., 
2004). Pipette pulled from a borosilicate glass tube (GC 150, Clark Electromedical 
Instruments, Pangbourne, UK) were fabricated on a model P-97 electrode puller (Sutter 
Instruments, Novato, CA, USA) and fire polished to give a final resistance of 2 – 3 MΩ 
for whole-cell recording. A pipette solution filled micropipette containing a silver/silver 
chloride electrode was gently lowered onto the surface of the cell membrane. By 
applying gentle suction to the pipette, a giga-seal was formed between the pipette and 
the cell membrane. Further suction ruptured the patch of the membrane under the tip of 
the micropipette, providing access for the microelectrode to the interior of the cell; and 
then the configuration of the whole cell recoding mode was achieved. 
To isolate IKN from other voltage-dependent K+ currents, cells were clamped at 0 mV for 
at least 5 minutes as described previously (Gurney et al., 2003). The patch-clamp 
amplifier was Axopatch 200 B (Axon Instruments, Foster City, CA) and the digital-analog 
converter was DigiData 1320 (Axon Instruments, Foster City, CA) in all voltage- and 
current-clamp experiments. Offset potentials were nulled directly before formation of a 
seal. No leak subtraction was made. Cells expressing holding current at -70 mV of 10 
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pA before or during the recordings were discarded. Estimation of cell capacitance (in pF) 
was made from whole-cell capacitance compensation. For resting membrane potential, 
cells were held in current-clamp at their resting Em (without current injection). The 
effective corner frequency of the low-pass filter was 0.5-5 kHz. The frequency of 
digitization was at least twice that of the filter. The data were stored and analyzed with 
commercially available pCLAMP 9.0 software (Axon Instruments, Foster City, CA, USA). 
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6.3 Preparation of human pulmonary artery smooth muscle cells 
 
The primary human pulmonary artery smooth muscle cells (PASMC) for this study were 
either purchased from Lonza (Lonza Group Ltd, Switzerland) and maintained according 
to the manufacturer's instructions or isolated from human pulmonary arteries of lung 
cancer patients (n = 39) undergoing lung surgery without a history of pulmonary 
vascular disease or arterial hypoxemia. The study protocol for tissue donation was 
approved by the “Institutional Review Board” of the Justus-Liebig-University Gießen and 
the Medical University of Graz in accordance with the national law and with the 
guidelines on Good Clinical Practice/International Conference on Harmonization. 
Written informed consent was obtained from each individual patient. 
 
  A 
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    B 
 
 
 
Fig 4: Immunofluorescence staining for smooth muscle cell  
At least 95% of cells alpha-actin (A) and myosin heavy chain-7 (B) stained positive in 
human pulmonary smooth muscle cells. 
 
Preparation procedure of the primary human PASMCs: The adventitia of small arteries 
with diameters of <1 mm was carefully removed under microscopic guidance and media 
pieces <1 mm3 were placed on 16-mm coverslips with 500 μl culture medium (Lonza 
SMC Medium; Lonza Group Ltd, Switzerland). Cells were maintained at 37 °C. Medium 
was initially changed after 24 h and every 48 h thereafter. PASMCs grown on coverslips 
were used for patch-clamp recordings within 6 days. Cells were sub-cultured in Petri 
dishes to 70 – 90 % confluent at passages 3–6 for molecular biology studies. SMC 
identity was verified by their characteristic appearance in the phase-contrast microscopy. 
The purity of the PASMC cultures was confirmed using indirect immunofluorescent 
antibody staining for smooth muscle-specific isoforms of α-actin and myosin heavy 
chain-7(at least 95% of cells stained positive. Fig. 4), and lack of staining for von 
Willebrand factor. 
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6.4 Solutions and chemicals 
 
All compounds were purchased from Sigma Chemical Company (St. Louis, MO). Stock 
solutions of U-73122, OAG, R59949, Rottlerin, Gö6983 and KT5720 were prepared in 
DMSO and methanol separately. In addition, anandamide was dissolved in 50 (v/v)% 
ethanol in water. Application of the vehicle used in the study alone at a maximal 
concentration (1:1,000 dilution of DMSO, ethanol or methanol in Ringer bath solution) 
had no effect on K+ current or resting membrane potential. The pH of solutions 
containing drugs was tested and corrected to eliminate potential pH-induced effects. 
They were diluted with bath solution to the appropriate concentration on the day of the 
experiment. 
 
The interior of the pipette was filled with pipette solution (Table 1); pH has been adjusted 
to 7.2 with KOH. The pipette solution with K-methanesulphonate was to suppress Cl- 
currents. The free [Ca2+], calculated using Maxchelator 
(http://www.stanford.edu/%7Ecpatton/maxc.html), was 30 nM.  Cells were superfused 
at room temperature with bath solution-1 (Table 2); then the pH has been adjusted to pH 
7.3 with NaOH. When High-K+ - bath solution (bath solution-2) was applied, then the pH 
has been adjusted to pH 7.3 with NaOH. The hypoxic bath solution was bubbled with N2. 
This procedure produced pO2 values in the cell chamber of 24–30 mmHg under hypoxic 
conditions (ABL TM510, Radiometer, Copenhagen, Denmark), pH was 7.40.  
The isolated mouse lung was perfused with Krebs Henseleit buffer as shown below 
(Table 3), then the pH has been adjusted to 7.37 - 7.40 with NaHCO3. 
 
Solutions used for the study are listed below. 
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Table 1: Pipette solution  
(All concentration in mmol/L) 
 KCl K-methanesulphonate MgCl2 Na2ATP EGTA HEPES 
Composition 20 135 1 2 3 20 
 
 
Table 2: Bath Solution  
(All concentration in mmol/L) 
 NaCl KCl CaCl2 MgCl2 glucose Na2HPO4 KH2PO4 HEPES
Solution-1 140.5 5.5 1.5 1 10 0.5 0.5 10 
Solution-2 10 155 1.5 1 10 0.5 0.5 1 
 
 
Table 3: Krebs Henseleit buffer 
 (All concentration in mmole/L except hydroxyethylamylopectin) 
 NaCl KCl KH2PO4 CaCl2 MgCl2 glucose Hydroxyethylamylopectin
 120 4.3 1.1 2.4 1.3 13.32 5% [wt/vol] 
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6.5 Relative mRNA quantification 
 
Real-time PCR was used for the relative quantitation of the TASK-1, TASK-2, TASK-3, 
PRKCA, and PRKCE mRNA. Both, GAPDH and HMBS, were used as reference genes 
(as shown in table 4). The primers were designed to be intron-spanning where possible 
and maximal specific for the target genes. The reactions were performed in an ABI 7700 
Sequence Detection System (Applied Biosystems, Foster City, CA) using SYBR-Green I 
as fluorogenic probe in 25 μl reactions containing 2 μl cDNA sample, 1× qPCRTM 
Mastermix for SYBR Green I (Eurogentec, Seraing, Belgium), 45 pmol forward and 
reverse primer (Table 4). The cycling protocol was 1× (50 °C, 2 min); 1× (95°C, 6 min); 
45× (95 °C, 5 s; 60 °C, 5 s, 73 °C, 10 s). Data for the amplification curves were acquired 
after the extension phase at 73 °C. After amplification, a melting curve was recorded 
and analyzed in order to identify possible contributions of unspecific products to the 
fluorescence signal. Additionally, an agarose-gel analysis was performed to confirm the 
primary formation of a single specific PCR product. The background signal of the 
amplification curves was individually corrected for each gene using the signals recorded 
from cycle 3 to cycle 15-25, depending on the onset of the exponential signal increase. 
The threshold value for each gene was set in the middle of the overlapping region of the 
exponential phases. Each gene was measured in duplicate in two independent 
experiments. The Δct values for each target gene were calculated for both reference 
genes using the averaged ct values by the formula Δct = cttarget – ctreference. The Δct of 
both reference genes were averaged and used to calculate the ΔΔct value by ΔΔct = 
ΔctsiRNA – Δctcontrol. According to an amplification efficiency of approximately 2, the 
factors of differential target expression were calculated by f = 2-ΔΔct (the efficiencies for 
the amplification of the target genes were determined in pilot experiments and were all 
greater than 1.98 or 98%, respectively; data not shown). The error of the ΔΔct values 
was estimated from the average standard deviation of replicates using the error 
propagation by Gauss. 
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Table 4: 
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6.6 Design and transfection of siRNA for human TASK-1 
 
The target sequence of siRNA was localized 261 bases downstream from the start 
codon of human TASK-1 (GenBank accession no. AF006823). The forward and reverse 
strands (UCA CCG UCA UCA CCA CCA U dTdT) and (AGU GGC AGU AGU GGU 
GGU A dTdT) with two 5’ deoxy-thymidine overhangs were commercially synthesized 
(Eurogentec, Seraing, Belgium) and annealed at a final concentration of 20 μmol/L each 
by heating at 95 °C for 1 minute and incubating at 37°C for 1 hour in annealing buffer 
(20 mmol/L Na-acetate, 6 mmol/L HEPES–KOH [pH 7.4], and 0.4 mmol/L Mg–acetate). 
Transfection of siRNA was performed at a final concentration of 40 nmol/L using 
Oligofectamin (Invitrogen). As a control, a random siRNA sequence (siRNA-ran: UAC 
ACC GUU AGC AGA CAC C dTdt) prepared as described above was used. RNA and 
electrophysiological measurements were performed 48 to 72 hours after siRNAs 
transfection. For assessment of the transfection efficiency, a fluorescein isothiocyanate 
(FITC)-conjugated siRNA (QIAGEN) was used. The intracellular localization was 
assessed by direct visualization of the FITC by fluorescence microscopy after 
transfection. 
 
 
6.7 Immunoprecipitation 
 
Cultured smooth muscle cells were solubilized as previously described (Vadasz et al., 
2005) in an extraction buffer supplemented with 1 mmol/L sodium orthovanadate, 10 
mmol/L sodium pyrophosphate, 5 mmol/L β-glycerophosphate, and 50 mmol/L sodium 
fluoride. The TASK-1 was immunoprecipitated from cell lysates (4 hours; 4 °C) using 
rabbit anti–TASK-1 (Alomone Labs, Jerusalem, Israel)(Hsu et al., 2004). Antibodies 
were chemically coupled to protein A–Sepharose beads using a Seize 
Immunoprecipitation Kit (Pierce, Rockford, Ill). Immunoprecipitates were washed to a 
final stringency of 470 mmol/L NaCl in extraction buffer. Immunoprecipitates were 
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resolved on a 10% Tris–Tricine SDS-PAGE gel, and blots were probed with rabbit 
anti–TASK-1 (1:500; Alomone Labs), mouse anti-phosphotyrosine (1:1750; Cell 
Signaling Technologies, Beverly, Mass), or mouse anti-phospho(Ser/Thr) (1:1000; Cell 
Signaling Technologies) antibodies, respectively. 
 
 
6.8 Immunofluorescence staining 
 
Immunofluorescence, as previously described, was performed using two different 
antibodies directed against unique domains of TASK-1, one at the amino terminus 
(Santa Cruz Biotechnology) and the other between residues 252 and 269 of the 
protein’s carboxyl terminus (Alomone Labs)(Gurney et al., 2003). hPASMCs grown on 
glass slides were fixed for 5 minutes in cold methanol, rinsed 5 times in PBS. After 
blocking with 1% BSA overnight, cells were incubated with anti-TASK-1 antibody (1:50 
dilution) for 1 hour then probed for 40 minutes with fluorescent labelled secondary 
antibodies (anti-goat IgG-FITC or anti-rabbit Alexa 555). Cells were counterstained with 
DAPI to identify the nuclear DNA. Duplicates were processed without primary antibodies 
as controls. Fluorescence was imaged with a Leica DM2500 M microscope, using Leica 
40x (N.A. 1.0) objective. 
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6.9 Isolated, perfused and ventilated mouse lungs 
 
All organ experiments were approved by the local authorities. Lungs from C57BL/6 mice 
(Charles River, Germany) were removed from the chest in deep anaesthesia 
(Weissmann et al., 2006) (pentobarbital sodium; 100 mg/kg body weight) while being 
perfused with Krebs Henseleit buffer (Table 3). The total system volume was 15 ml, the 
buffer flow rate was 2 ml/min, and left atrial pressure was set at 1.5 - 2.0 mm Hg. The 
isolated lungs were ventilated with a gas containing 5.3 % CO2, 21.0 % O2, balanced 
with N2 (positive pressure ventilation with a tidal volume of 300 μl, 90 breath/min, and 3 
cmH2O positive end-expiratory pressure). The isolated lungs were freely suspended 
from a force transducer for continuous monitoring of organ weight. The whole system 
was heated to 37° C. Pressures in the pulmonary artery, the left atrium and the trachea 
were continuously registered. Lungs included in the study were those that had a 
homogeneous white appearance with no signs of hemostasis, edema or atelectasis. 
After an initial steady state period of 30 min, ET-1 was added in to the buffer in 
increasing doses every 25 min. In experiments with anandamide this agent was applied 
to the buffer 20 min prior to the first ET-1 admixture. Delta PAP indicates the pulmonary 
arterial pressure after application of ET-1 at a chosen concentration minus the 
pulmonary arterial pressure before. 
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Fig 5. Scheme of the isolated perfused mouse lung. 
The perfusion system is drawn in black, the ventilation system in gray. Water circulation 
system is marked by black waves. From (von Bethmann et al., 1998) 
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6.10 Statistical analysis 
 
Numerical values are given as means ± SE of n cells. Intergroup differences were 
assessed by a factorial analysis of variance with post hoc analysis with Fisher’s 
least-significant difference test or Student’s unpaired and paired t tests as appropriate. 
Probability values of <0.05 were considered significant. The mean data at different 
anandamide concentrations were fitted. 
To determine the blocking potency of endothelin-1 on TASK-1, concentration–inhibition 
curves were constructed from the current inhibition by the drug at 0 mV. I/I0 is the 
current in the presence of ET-1 as a fraction of the current before ET-1 application. The 
normalized amplitudes of currents were fitted by means of a nonlinear least-squares 
method with the best-fit Hill equation: E=Emax/(1+(IC50/c)h), where E is the percentage 
for inhibiting IKN at a concentration c of the drug concentration, Emax was the maximum 
effect, IC50 was the concentration giving a half-maximum effect and h was the Hill 
coefficient. Because the Hill coefficient was less than 1 (0.9 in all curves), it was set to 
one, accounting for a 1:1 binding stoichiometry. 
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7. Results 
 
7.1 Characteristics of K2P channel in hPASMC 
 
7.1.1 Expression of TASK-1 channels 
The TASK-1 protein in hPASMC was established with two TASK-1 antibodies, 
anti-rabbit Alexa 555 antibodies or anti-goat IgG-FITC antibodies, directed against the 
carboxyl or amino terminal region of the protein, respectively (n=4; Figure 6A and 6B). In 
contrast, staining was absent in control cells treated in the same way but without an 
exposure to a TASK-1 antibody (Figure 6C and 6D). PCR studies demonstrated the 
presence of TASK-1, TASK-2, and TASK-3 in human brain tissue, but only TASK-1 
mRNA was detected in primary and in cultured hPASMC as well (Figure 6E). 
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Fig 6. TASK-1 expression in hPASMC. (from Olschewski et al., 2006)  
Fluorescence images of hPASMC stained with the Alomone C-terminal TASK-1 with  
anti-rabbit Alexa 555 antibodies (A) or the Santa Cruz N-terminal TASK-1 with anti-goat 
IgG-FITC antibodies (B). Staining was absent in control cells treated identically but 
without an exposure to the primary antibody, as shown by matched fluorescence (C and 
D, respectively). (E) The Representative gel shows mRNA expression of TASK-1 (91 
bp), TASK-2 (94 bp), and TASK-3 (104 bp) in human brain tissue (B), primary hPASMC 
(F), and cultured hPASMC (K). Only TASK-1 is expressed in primary and cultured 
hPASMC. The arrow indicates 100 bp: M, the molecular weight marker used to indicate 
the size of the PCR fragments: N, no template control. Identical results were obtained 
with at least 3 additional preparations of RNA. 
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7.1.2 The pharmacological properties of TASK-1 channels 
 
Anandamide, a member of the endogenous cannabinoids, has been recently shown to 
be a direct and selective blocker of the TASK-1 channels (Gurney et al., 2003),(Maingret 
et al., 2001). As depicted in Figure 7, the application of 10 μmol/L anandamide markedly 
but reversibly inhibited the noninactivating K+ current (IKN) in primary hPASMC from 16
±2 pA to 6±2 pA (P<0.05), recorded at 0 mV after the cells were clamped at 0 mV for 
at least 5 minutes to inactivate voltage-dependent K+ channels. Figure 7A showed a 
representative recording from the holding potential of 0 mV; the voltage was stepped to 
60 mV and then ramped to -100 mV over a period of 1.6 seconds. The current during the 
ramp reflects IKN parallel with a nonspecific “leak” current and reverses direction at the 
resting potential of the hPASMC (Gurney et al., 2003),(Osipenko et al., 1997). As a 
consequence of the inhibition of the outward current, anandamide also influenced the 
reversal potential of the current (Figure 7A). The “difference” current, obtained by 
subtracting the current remaining in the presence of anandamide from that obtained 
under control conditions (Figure 7B, inset), was reversed close to -84 mV, the calculated 
Nernst equilibrium potential for K+ under these conditions. Maintenance of a resting 
membrane potential in rabbit PASMC had been proposed to involve TASK-1(Gurney et 
al., 2003). Indeed, anandamide significantly depolarized hPASMC (9±1 mV; n=5; 
P<0.05). Under symmetrical K+ conditions in the same cell, anandamide caused a 
marked inhibition of the K+ current (Figure 7B). The difference current (inset) was linear 
and reversed at or near 0 mV, the calculated Nernst equilibrium potential for K+ under 
these conditions. This pharmacological and biophysical profile demonstrated the 
functional expression of the K+-selective background channel TASK-1 in primary 
hPASMC. 
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Fig 7: IKN in human PASMC (from Olschewski et al., 2006; recordings performed by Bi 
Tang and Yingji Li) 
(A) Effect of 10 μmol/L anandamide on IKN recorded during ramp, voltage protocol inset 
(left) and difference current trace, obtained by subtracting current amplitudes in the 
presence of TASK-1 blocker from those obtained under control conditions (right). 
Difference current reversed close to -84 mV, as expected for a K+-selective conductance 
under these conditions. (B) IKN evoked under symmetrical (155 mmol/L K+) conditions by 
ramp in the same cell (voltage protocol above), before (high-K+) and during the 
application of 10 μmol/L anandamide (left) and trace of difference currents (right). 
Difference current was voltage independent and reversed close to 0 mV, as expected 
for a K+-selective conductance under these conditions. 
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The essential property of the TASK-1 channels is their extreme sensitivity to variations 
in extracellular pH (pHo) in a narrow physiological range. Figure 8A shows the pHo 
dependence of IKN of primary hPASMC across the full voltage range over which IKN is 
apparent. Modification of IKN by pHo was reflected in the resting membrane potential. A 
pH of 8.3 significantly hyperpolarized the cells, whereas acidification caused membrane 
depolarization in primary hPASMC (-10±1 mV versus 13±2 mV; n=5). Overall, we 
have found a functional expression of kinetically and pharmacologically identical 
background K+ current carried by TASK-1 in primary hPASMC. In order to provide a 
certain evidence for the involvement of TASK-1 in IKN, we tested the effects of 10 
mmol/L tetraethylammonium (TEA, a blocker of KCa), 3 mmol/L 4-aminopyridine (4-AP, a 
blocker of KV), 5 μmol/L ruthenium red (a blocker of TASK-3), and different 
concentrations of ZnCl2. We found that TEA and 4-AP failed to inhibit IKN (Figure 8B). In 
contrast, ruthenium red caused a reduction of IKN (Figure 8C). However, the ruthenium 
red–sensitive current was linear and the reversal potential varied between 0 and -20 mV. 
The calculated Nernst equilibrium potential was -84 mV for K+. It is well known that the 
ruthenium red is active at various sites (eg, ryanodine receptors (Hohenegger et al., 
2002) and TRPV channels (Guler et al., 2002), therefore, this effect in primary hPASMC 
was not be surprising. The divalent zinc cation was also reported to inhibit TASK-1 at 
higher concentrations. However, in our study, the Zn-sensitive ion current had a reversal 
potential close to 0 mV (Figure 8D), indicating the presence of a nonspecific leak 
current. 
Both, the potency of anandamide and pH 6.3 for blocking IKN, and pH 8.3 for activating it, 
together with their effects on measured resting membrane potential (Em), strongly 
suggest that IKN maintains the resting membrane potential in primary hPASMC. 
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Fig 8. Characterization of IKN in hPASMC (from Olschewski et al., 2006)     
(A) Representative time-course plot of IKN at different pHo in primary hPASMC recorded 
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by ramp, activated from a holding potential of 0 mV during 1.6 second from 60 to -100 
mV(left). Relationship between pHo and IKN measured at 0 mV (right). Data were fitted 
with a Boltzmann relationship with pH0.5 7.3 for primary hPASMC. (B)TEA (10 mmol/L) 
and 4-AP (3 mmol/L) failed to inhibit IKN. (C) Effect of ruthenium red on IKN recorded 
during ramp in primary hPASMC (left), and “difference” currents trace, obtained by 
subtracting the current amplitudes in the presence of ruthenium red from those obtained 
under control conditions (right). Difference current reversed close to 0 mV. (D) Effect of 
ZnCl2 on IKN in hPASMC recorded during ramp, and “difference” currents trace (insert). 
Difference current reversed closed to 0 mV. The histogram summarized the effect of 
different concentrations of ZnCl2 on IKN calculated at 0 mV in cultured hPASMC (n = 4 
each group). I/I0 is the current in the presence of ZnCl2 expressed as a fraction of the 
current prior to the ZnCl2 application. 
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7.1.3 The Effects of TASK-1 knockdown in hPASMC 
 
In order to further confirm the role of the TASK-1 channels in the regulation of Em in 
hPASMC, we knocked down the TASK-1 expression in the cells via TASK-1 siRNA. 
Electrophysiological measurements were performed 24 to 48 hours after transfection of 
siRNAs. We found that the TASK-1 siRNA efficiently suppressed TASK-1 mRNA levels 
without affecting other widespread enzyme systems such as protein kinase C (PKC) 
(Figure 9A). The knockdown of TASK-1 caused a depolarization of the resting 
membrane potential compared to the control cells (-26±1 mV versus -40±2 mV; P<0.05; 
Figure 9B). As shown in Figure 9C, pretreatment of hPASMC with TASK-1 siRNA 
inhibited the suppression of IKN by anandamide or acidosis (from 3±1 pA to 2±1 pA, 
from 3±1 pA to 3±1 pA, respectively). There was no significant activation of alkalosis 
(from 4±1 pA to 3±1 pA). However, IKN was demonstrated to be inhibited by acidosis 
or anandamide, and activated by alkalosis in hPASMC transfected with scrambled 
sequence TASK-1 siRNA (Figure 9D and 9E). Therefore, these results strongly suggest 
that TASK-1 is a major contributor to IKN, and further confirm the role of the TASK-1 
channels in the regulation of Em in hPASMC. 
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Fig 9.  Effects of TASK-1 knockdown on hPASMC (from Olschewski et al., 2006; 
recordings performed by Bi Tang and Yingji Li) 
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(A) Regulation of human TASK-1 (hTASK-1), human PKCα (hPKCA), and human PKCε 
(hPKCE) as measured by real-time RT-PCR (*P<0.05, 1-sample t test with H0: ΔΔCt=0). 
The ΔΔCt values are calculated as described in chapter 6. Positive values indicate an 
upregulation of the target gene compared to controls; negative values a downregulation. 
The ΔΔCt values are approximately proportional to the binary logarithm of the fold 
change. (B) Resting membrane potential of native control, and transfected cells shown 
left (*P<0.01). The Em is significantly depolarized in transfected cells. Lack of changes in 
Em under anandamide or pHo in transfected cells (n=5 each group). (C) Effect of 10 
μmol/L anandamide and pHo on remaining IKN recorded at 0 mV. Effect of pHo (D) and 
10 μmol/L anandamide (E) on remaining noninactivating current (IKN) recorded at 0 mV 
in hPASMC transfected with scrambled sequence TASK-1 siRNA. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 7                  RESULTS                         PAGE 40
 
7.1.4 Acute hypoxia inhibits TASK-1 
 
Due to previous work that implicated the TASK-1 channel as an important molecular 
component of the O2-sensitive K+ current in PASMC (Gurney et al., 2006), we 
investigated the O2 sensitivity of this channel in primary hPASMC. Representative 
traces recorded by ramp, before and after five minutes of exposure to hypoxic solutions, 
are shown in Figure 10A. The hypoxia-sensitive current reversed close to -84 mV. 
Consistent with the involvement of the TASK-1 channels in this inhibition, the current 
was not further blocked through anandamide (Figure 10A, bottom panel). Under 
current-clamp conditions, hypoxia caused a marked cell depolarization (by 10±1 mV; 
n=9; P <0.05). Pretreatment of hPASMC with TASK-1 siRNA inhibited significant 
suppression of IKN by hypoxia (Figure 10B). Figure 10C summarizes the mean data 
confirming that hypoxia significantly inhibited TASK-1 in primary hPASMC. 
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Fig 10. Hypoxia blocks TASK-1 in hPASMC (from Olschewski et al., 2006)  
(A) Effect of hypoxia on IKN recorded by ramp in primary hPASMC (left) and difference 
currents trace, obtained by subtracting the current amplitudes in the presence of 
hypoxia from those obtained under control conditions (right). Difference current 
reversed close to -84 mV, as expected for a K+-selective conductance under these 
conditions. EK-Nernst indicates Nernst equilibrium potential. Application of 10 μmol/L 
anandamide under hypoxic conditions did not cause a further change in the current 
(bottom), suggesting that the hypoxia-sensitive current is carried by TASK-1. (B) Lack of 
hypoxia effect on IKN in siRNA-transfected hPASMC. (C) The histogram summarizes the 
effect of hypoxia and anandamide (anan) under hypoxic conditions on IKN calculated at 0 
mV in primary and siRNA-transfected hPASMC (n=5 each group; **P<0.01). 
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7.2 Modulation of TASK-1 by endothelin-1 in hPASMC 
 
7.2.1 Endothelin-1 inhibits TASK-1 
 
As shown in figure 11A, ET-1 significantly and dose-dependently depolarized hPASMCs. 
Application of ET-1 markedly reduced the non-inactivating K+ current in primary 
hPASMCs in the presence of the voltage-gated K+ channel inhibitor 4-aminopyridine 
(4-AP) (5 mM, data not shown). Figure 11B shows the effect of ET-1 in representative 
recordings from the holding potential of 0 mV, after the cells were clamped at 0 mV for at 
least 5 min to inactivate the voltage-dependent K+ channels. The voltage was stepped to 
60 mV and then ramped to -100 mV over a period of 1.6 seconds. The ET-1-sensitive 
current, obtained by subtracting the current remaining in the presence of ET-1 from that 
obtained under control conditions (Figure 11B insert), was reversed close to -84 mV, the 
calculated Nernst equilibrium potential for K+ under these conditions. The effect of ET-1 
on IKN was completely abolished by pre-application of 10 μM anandamide (Figure 11C), 
a TASK channels blocker (Gurney et al., 2003), (Maingret et al., 2001). Due to our data 
showing that TASK-2 and TASK-3 are not expressed in hPASMC, this finding suggests 
that ET-1 acts on the TASK-1 current. Another property of TASK channels is their 
sensitivity to extracellular pH and to volatile anesthetics. As illustrated in Figure 11E 
(left), the ET-1 inhibited current was not further reduced by acidosis (pH 6.3). 
Consistently, reducing the pH from 7.3 to 6.3 suppressed IKN. Under this acidification, 
ET-1 did not further inhibit the current (Figure 11E, right). Application of isoflurane, well 
known activator for TASK-1, (1mM) enhanced IKN (Figure 11F). Consistent with the 
involvement of the TASK-1 channels in this facilitation, IKN was blocked by ET-1. The 
concentration-response curve for TASK-1 inhibition by ET-1 measured and calculated at 
0 mV resulted in an IC50 of 1.6 ± 0.3 nM (Figure 11D; n = 5 for each group).  
 
In order to further confirm the role of TASK-1 in the ET-1 pathway in hPASMC, we 
knocked down TASK-1 expression using TASK-1 siRNA. In the siRNA transfected cells, 
no inhibition of the remaining current by ET-1 was detected compared to control primary 
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hPASMC (Figure 12A) or to scrambled-siRNA transfected hPASMCs (not shown). The 
histograms in Figure 12B summarize the effect of ET-1 on IKN calculated at 0 mV, 
showing that there was no significant inhibition by ET-1 on the remaining current after 
siRNA-treatment. In addition, the siRNA transfected cells showed a significantly less 
negative membrane potential (-31 ± 1 mV, p < 0.001, n = 6) compared to control cells 
(-51 ± 1 mV, n = 45). It is noteworthy that in the siRNA-transfected cells ET-1 did not 
further change the membrane potential (from -31 ±1 mV to -29 ± 1 mV, p > 0.05, n = 6) 
suggesting the crucial role of TASK-1 in the ET-1 pathway. In order to investigate the 
possible physiological relevance of TASK-1 for ET-1 induced pulmonary 
vasoconstriction, we analyzed the ET-1-induced pressor response in isolated perfused 
mouse lungs. ET-1 induced a dose-dependent increase in PA pressure (Figure 13). The 
PA vasoconstriction was more pronounced when anandamide was given prior to the 
ET-1. The application of 8 nM ET-1 increased pulmonary arterial pressure (PAP) with 
15.6 ± 2.3 mmHg. When anandamide was given prior to ET-1, the increase was 23.8 ± 
1.0 mmHg (p < 0.01, n =5). These results suggest that ET-1 induced pulmonary 
vasoconstriction partially via TASK-1 channel inhibition. 
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Fig. 11. ET-1 blocks IKN. (from Tang et al.; 2009) 
(A) ET-1 significantly depolarized primary human PASMCs (n = 5 each group; *, p < 
0.05, ***, p < 0.001). (B) Effect of 10 nM ET-1 on IKN recorded during ramp, voltage 
protocol and “difference” currents trace, obtained by subtracting the current amplitudes 
in the presence of ET-1 from those obtained under control conditions (top). Difference 
current reversed close to -84 mV, as expected for the K+-selective conductance under 
these conditions. (C) Effect of anandamide on the ET-1-induced TASK-1 current 
inhibition. Mean amplitudes of currents ± SEM measured in experiments as indicated. 
The amplitudes were normalized to the current amplitude obtained with the first 
recording without drugs (control, black column) (n = 5 each group; ***, p < 0.001 
difference from control). (D) Concentration-response curve for ET-1. I/I0 is the current in 
the presence of ET-1 expressed as a fraction of the current prior to ET-1 application. 
The line is fitted with Hill equation using an IC50 of 1.6 ± 0.3 nM. (E, left) Representative 
recordings for IKN after applying ET-1 (10 nM) and after ET-1 application at pH 6.3. (E, 
right) IKN recorded in control, following acidification to pH 6.3 and after application of 
ET-1 (10 nM) under acidification. (F) ET-1 reverses IKN opening by isoflurane (1 mM). 
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Fig 12.  Impact of ET-1 on IKN in TASK-1-siRNA-transfected hPASMCs. (from Tang 
et al.; 2009) 
(A) Lack of the ET-1 (10 nM) effect on IKN in TASK-1-siRNA transfected hPASMCs. (B) 
The histogram summarizes the effect of ET-1 on IKN calculated at 0 mV in control and 
siRNA-transfected primary hPASMCs (n = 6 each group; ***, p < 0.001). 
 
 
Fig 13. Effect of ET-1 on the isolated perfused mouse lungs (from Tang et al.; 2009; 
performed by Norbert Weissmann). 
ET-1 increased the pulmonary arterial pressure (PAP) in isolated perfused lungs in a 
dose dependent manner. The ET-1-induced vasoconstriction (delta PAP after ET-1 
application) was reduced when anandamide was applied before ET-1 compared to the 
sole ET-1 treatment (n = 5 each group; ***, p < 0.001). 
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7.2.2 The ET-1 signaling pathway 
 
In human, ET-1 binds to two types of receptors, ETA and ETB. Both G 
protein-coupled-receptors were detected in PASMCs. In order to investigate which 
receptor is involved in the inhibition of TASK-1 by ET-1, we used different ET-1 receptor 
antagonists: BQ123 (ETA blocker; 1 μM), BQ788 (ETB blocker; 1 μM), and PD142893 (a 
non-specific ETA+B blocker; 100 nM). The ET-1 induced TASK-1 inhibition was 
completely abolished by pre-application of BQ123 and PD142893 (Figure 14A and C). 
In contrast, pre-application of BQ788 had only a negligible effect on the ET-1-induced 
inhibition of TASK-1 (Figure 14B and C), suggesting that the ETA receptor mediates the 
TASK-1 response to ET-1. Caveolins are involved in multiple cellular processes such as 
calcium homeostasis(Hardin et al., 2006) and signal transduction(Williams et al., 
2004),(Cohen et al., 2004). Moreover, ETA receptors are localized within caveolae(Chun 
et al., 1994). Thereby, we investigated the possible involvement of caveolae and 
phosphorylation of TASK-1 in the ET-1-mediated signal transduction in human PASMCs. 
PASMC were first analyzed for TASK-1 and caveolins via western blot analysis. In 
hPASMC we detected caveolin 1, 2 and 3, but the coimmunoprecipitation studies did not 
indicate any interaction among TASK-1 and these caveolins after ET-1stimulation 
(Figure 15). 
 
In order to further assess the mechanisms involved in ET-1-induced TASK-1 inhibition, 
hPASMCs were incubated for 10 min with ET-1 (10 nM). No differences in the tyrosine 
phosphorylation of TASK-1 was observed when ET-treated and untreated groups were 
compared (n = 3; Figure 16). In contrast, the incubation with ET-1 stimulated the 
threonine phosphorylation of TASK-1, as was evident in TASK-1 immunoprecipitates 
probed with an anti-phosphothreonine antibody (Figure 16). Protein loading equivalence 
was demonstrated by probing immunoprecipitates with an anti–TASK-1 antibody (Figure 
16). In patch-clamp studies, various PKC inhibitors, including Ro318220 (1 μM), 
Gö6983 (10 nM) and rottlerin (10 nM) were used on the non-inactivating current 
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response to ET-1 to confirm the PKC action. The pretreatment of the cells with the 
broad-spectrum PKC blocker Ro318220 and the classic, fast acting PKC inhibitor 
Gö6983 abolished the effect of ET-1 on the TASK-1 current (Figure 17). Rottlerin, a 
selective PKCδ inhibitor, partially blocked the inhibition of TASK-1 by ET-1. Consistent 
with the effects of the PKC inhibitors, preincubation with the PKA inhibitor KT5720, did 
not lead to any change in ET-1 dependent TASK-1 inhibition (not shown). Collectively, 
these results lead to the suggestion that in hPASMC TASK-1 channels are inhibited by 
ET-1 primarily through the PKC-dependent pathways. 
 
PKC may be activated in response to diacylglycerol (DAG) and inositol 
1,4,5-triphosphate (IP3)-stimulated increased cytosolic calcium generated via 
phospholipase C (PLC). To address the ET-1 signaling pathway downstream of the G 
protein-coupled receptor ETA, we combined pharmacological approaches with 
patch-clamp studies. First, we investigated the involvement of PLC-dependent signaling 
pathway(s) using the PLC antagonist U-73122 on the ET-1 induced TASK-1 inhibition. 
Pre-application of U-73122 in hPASMCs completely abolished the effect of ET-1 (10 nM) 
on IKN (Figure 18A). Phosphatidylinositol 4,5- biphosphate (PIP2) serves as a substrate 
for the hydrolysis by PLC to produce inositol 1,4,5-triphosphate (IP3) and diacylglycerol 
(DAG). Thus, hPASMCs were dialyzed with the PIP2 scavenger poly-lysine (30 μg/ml), 
widely used to demonstrate the regulation of channels by endogenous PIP2 and then 
superfused with ET-1 (10 nmol/L). Cells dialyzed with the internal control solution were 
used as a control. The application of poly-lysine alone significantly reduced the current 
density to or below the level recorded after an ET-1 application. When ET-1 was 
simultaneously applied, it did not block TASK-1 (Figure 18B). Next, in order to determine 
whether IP3 or DAG is required for the PKC activation, we incubated hPASMC with the 
DAG kinase inhibitor R-59949 (30 μM) prior to ET-1 (10 nM). R-59949 inhibited TASK-1 
(Figure 18C and D). Similar data were obtained when OAG (a DAG analogue, 100 μM) 
was applied prior to ET-1 in hPASMC. Application of OAG alone led to a significant 
inhibition of the TASK-1 current, similar to the effect of ET-1 alone. Thus, the TASK-1 
current was not further blocked when ET-1 was additionally applied, as shown in Figure 
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18E and F. Taken together; these results indicate that the ETA-PLC-PIP2-DAG-PKC 
pathway is essential for the inhibition of TASK-1 by ET-1 in primary human PASMCs. 
 
 
Fig 14. Blockade of the ETA receptor abolishes the ET-1 effect. (from Tang et al.; 
2009)  
(A) and (B) Non-inactivating current TASK-1 channels in response to an ET-1 
application in the presence of BQ123 (ETA receptor antagonist; 1 μM) or BQ788 (ETB 
receptor antagonist; 1 μM). Human PASMCs were pretreated for 1 h with the inhibitors 
prior to the addition of ET-1 (10 nM). (C) The histogram summarizes the effect of ET-1 
on the TASK-1 current after pretreatment of hPASMCs with PD142893 (ETA+B 
antagonist 100nM), BQ123 or BQ788 (1 μM) (n = 6 each group; ***, p < 0.001 difference 
from ET-1-untreated cells). I/I0 is the current in the presence of ET-1 expressed as a 
fraction of the current prior to ET-1 application. 
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Fig 15. Effects of ET-1 on TASK-1 with caveolin (from Tang et al.; 2009; performed 
by Rory E. Morty). 
Primary human PASMCs were treated for 10 min with or without ET-1 (10 nM). 
Homogenates were immunoprecipitated with anti-TASK-1 antibody submitted to 
SDS-PAGE. Membranes were probed for caveolin-1, 2 or 3, and TASK-1. 
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Fig 16. PKC-dependent phosphorylation of TASK-1 by ET-1. (from Tang et al.; 2009) 
Representative results of the threonine (left) and tyrosine (right) phosphorylation of 
TASK-1 in ET-1-treated and untreated (control) hPASMCs. Protein loading equivalence 
is shown by probing immunoprecipitates with an anti-TASK-1 antibody in the lower 
panel. 
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Fig 17. Impacts of PKC inhibitors on the ET-1 effect. (from Tang et al.; 2009) 
(A) Representative traces show the lack of ET- 1 (10nM) effect on TASK-1 after 1 h 
preincubation with Gö6983 (10 nM). (B) The histogram summarizing the effect of ET-1 
on the TASK-1 current after pretreatment of hPASMCs with Ro318220 (1μM), Gö6983 
or rottlerin (10 nM) (n = 6 each group; **, p < 0.01; ***, p < 0.001 difference from 
ET-1-untreated cells). I/I0 is the current in the presence of ET-1 expressed as a fraction 
of the current prior to ET-1 application. 
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Fig 18. Downstream signaling pathway of the ETA receptors. (from Tang et al.; 
2009) 
(A) and (B) Mean amplitudes of currents ± SEM measured in experiments as indicated. 
The amplitudes were normalized to the current amplitude obtained with the first 
recording without drugs (control, black column). (C) Non-inactivating current of TASK-1 
channels in response to the application of the DAG kinase inhibitor R-59949 and 
R-59949 + ET-1. (D) Mean amplitudes of the current density ± SEM. Black column 
shows the control without preincubation with R-59949. (E) Non-inactivating current of 
TASK-1 channels in response to the application of the DAG analog OAG and OAG + 
ET-1. (F) Mean currents amplitudes ± SEM measured in experiments as indicated. The 
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amplitudes were normalized to the current amplitude obtained from the recording 
without drugs (control, black column) (n = 5 each group; ***, p < 0.001 difference from 
control).
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8. Discussion 
 
8.1. Two-Pore domain potassium channels in hPASMC 
 
Smooth muscle cells have negative resting potentials that are important for the 
regulation of the excitability and the contractile tissue properties. K+ channels play an 
essential role in the regulation of the resting membrane potential and are able to drive 
the resting membrane potential near the K+ equilibrium potential. Different types of K+ 
channels have been identified in pulmonary artery smooth muscle cells (PASMCs), 
including voltage-gated K+ channels (KV) (Post et al., 1995),(Weir et al., 1995), 
(Platoshyn et al., 2004), large-conductance Ca2+–activated channels (Albarwani et al., 
1994),(Peng et al., 1999), and ATP-dependent channels (KATP) (Nelson et al., 1995). 
The three kinds of channels are predominantly activated when the cell is stimulated. In 
contrast, a new group of recently described K+ channels, the background (leak) 
two-pore-domain (2P) K+ channels, are give rise to K+-selective currents that are open 
at all voltages when these superfamily of 2-PK channels are functionally expressed 
(Gurney et al., 2003),(Gardener et al., 2004). It has become clear that the newly 
identified KCNK family of K+ channel subunits also contribute to the K+ current in 
smooth muscle cells (Gurney et al., 2003),(Gardener et al., 2004). A decrease in the 
leak K+ conductance leads to a cell depolarization that enhances the open probability of 
L-type Ca2+ channels in smooth muscle cells, resulting in a periodic Ca2+ entry and 
finally in vasoconstriction. 
In this study, we demonstrated the expression of TASK-1 mRNAs and proteins in 
hPASMCs. Moreover, our antibody staining shows a TASK-1 expression at the 
membrane surface, compatible with a functional role in mediating the membrane K+ 
currents. We have found an anandamide-sensitive conductance in primary hPASMC 
that had properties similar to the TASK-1 channels. The native conductance shows an 
outward rectification in the low external K+ solution, instantaneous and noninactivating. 
It is activated by alkalotic pH or potentiated by isoflurane, and blocked by anandamide 
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and Zn2+. It is insensitive to TEA and 4-AP. Transfection of TASK-1 siRNA into hPASMC 
significantly depolarizes the resting membrane potential and abolishes the effect of pH 
and anandamide. Furthermore, we are able to show the hypoxia sensitivity of the 
TASK-1 current. We conclude that TASK-1 channels are responsible for the hypoxia- 
and pH-sensitive, voltage-independent background conductance that sets the resting 
membrane potential in hPASMC. 
The results of our experiments exclude the possibility that classical voltage-sensitive, 
Ca2+-sensitive, and ATP-sensitive K+ channels play a significant role in mediating the 
observed pH-induced changes in the membrane potential. TASK-1 is very sensitive to 
variations in the extracellular pH in a narrow physiological range which has been 
reported in many different cell types (Duprat et al., 1997),(Buckler et al., 2000),(Reyes et 
al., 1998). Local pH changes caused by physiological or pathophysiological conditions, 
such as hypo- or hyperventilation or ischemia in the pulmonary vascular bed, may result 
in acidosis or alkalosis and lead to changes in the pulmonary artery pressure. Our data 
suggest that the effects on the pH-sensitive ion channels may also explain the 
acidosis-induced vasoconstriction and the alkalosis-induced vasodilatory responses. 
Furthermore, anandamide, a selective TASK-1 blocker, significantly reduces IKN and 
causes a depolarization similar to that seen at pH 6.4. This observation is consistent 
with results reported in earlier studies (Gurney et al., 2003),(Maingret et al., 
2001),(Leonoudakis et al., 1998). In a symmetrical K+ concentration, the I/V curve for IKN 
becomes linear and anandamide inhibits a voltage-independent current with a reversal 
potential close to 0 mV, demonstrating that TASK-1 behaves as a pure K+-selective leak 
channel. Taken together, these data provide an unequivocal biophysical and 
pharmacological evidence for the functional expression of TASK-1 in primary hPASMC. 
The application of TASK-1 small interfering RNA provides further evidence to link the 
resting membrane potential and TASK-1 channel. The resting membrane potential is 
significantly decreased in transfected cells. Moreover, the loss of sensitivity of the 
membrane potential to a significant depolarization by anandamide and pH 6.4, or to a 
significant hyperpolarization by pH 8.4 in transfected cells, strongly implicates TASK-1 
as a major contributor to the resting membrane potential. 
CHAPTER 8                   DISCUSSION                       PAGE 57
Acute hypoxic inhibition of K+ channels is a critical step in the regulatory processes 
designed to link the lowering of O2 levels to cellular responses. It is often questioned 
whether the K+ channels are active at sufficiently negative potentials to set the resting 
membrane potential of PASMC and whether K+ channels are able to mediate hypoxic 
pulmonary vasoconstriction. Since hypoxia depolarizes pulmonary artery smooth 
muscle cells (Post et al., 1992), it is thought that an oxygen-sensitive component of the 
resting membrane potential may contribute to this hypoxia-induced pulmonary 
vasoconstriction (HPV). Importantly, IKN in both rabbit (Osipenko et al., 1997) and 
human PASMC is inhibited reversibly by acute hypoxia, which is compatible with it being 
responsible for the oxygen sensitivity of the membrane potential. Based on the 
compelling evidence, we know that TASK-1 is a major contributor to IKN and that its 
inhibition by hypoxia underlies hypoxia-induced depolarization. These discoveries are 
consistent with the role of the TASK channels in the background conductances of other 
cell types, such as IKSO (a ‘‘standing-outward’’ K+ current, an outwardly rectifying 
potassium current) in cerebellar granule neurons (Millar et al., 2000) and the 
oxygen-sensitive current in cells of the carotid body (Buckler et al., 2000). 
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8.2. TASK-1 regulation by endothelin-1 
 
Endothelin plays a central role in the pathogenesis of pulmonary hypertension and has 
been extensively studied. Our results provide evidence that endothelin modulates the 
native background two-pore domain K+ channel TASK-1 in primary human pulmonary 
artery smooth muscle cells which sets their membrane potential, as above shown by 
means of TASK-1-siRNA studies. Consequently, ET-1 depolarizes the resting 
membrane potential of hPASMCs at clinically relevant concentrations by a 
dose-dependent inhibition of TASK-1. These effects are abolished by antagonists of the 
G protein-coupled-receptor ETA, the PIP2 scavenger and the inhibitors of PLC, DAG 
kinase, and PKC. 
The effects of endothelin on pulmonary vessels is the matter of a continued interest, 
because an activated endothelin system significantly contributes to the pathological 
changes in pulmonary hypertension (Stewart et al., 1991),(Giaid et al., 1993). 
Endothelin receptor antagonists have been shown to be effective for the therapy of 
pulmonary arterial hypertension (Rubin et al., 2002). Circulating or lung tissue levels of 
ET-1 are elevated in animal models of PAH (Miyauchi et al., 1993),(Ivy et al., 
1998),(Frasch et al., 1999),(Nakanishi et al., 1999) as well as in human PAH (Stewart et 
al., 1991),(Giaid et al., 1993),(Kumar et al., 1996),(Yoshibayashi et al., 1991). In 
addition, a correlation between an increased ET-1 expression in the lung of patients with 
pulmonary hypertension and the severity of the disease was demonstrated (Giaid et al., 
1993). Although multiple evidences indicate that the endothelin system plays a key role 
in the pathogenesis of pulmonary hypertension, the molecular targets of ET-1 have not 
been clearly defined in detail until now. Under normoxic conditions, the acute 
ET-1-induced vasoconstriction occurs via a Ca2+-dependent mechanism, mainly by Ca2+ 
influx through voltage-activated calcium channels, secondary to K+ channel inhibition 
and membrane depolarization. To date, the involvement of voltage-activated K channels 
(Shimoda et al., 2001) or ATP-dependent K channels (Park et al., 2005) has been 
established. In human PASMC, our previous study demonstrated that only TASK-1 
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channels, a member of the background two-pore domain K+ channel family are 
identified. If these channels are functionally expressed, they give rise to the K+-selective 
current that is open at all voltages, in contrast to the KV or KATP channels whose activity 
is controlled by voltage or metabolic regulation. In fact, background K+ channels such as 
TASK-1 set the resting membrane potential in excitable cells (Millar et al., 2000),(Backx 
et al., 1993),(Patel et al., 1999),(Talley et al., 2002),(Talley et al., 2003),(Sirois et al., 
2000). Due to the fact that TASK-1 is active at rest in hPASMC, its inhibition would lead 
to a cell depolarization that enhances the open probability of the L-type Ca2+ channels in 
smooth muscle cells, causing a periodical Ca2+ entry as well as vasoconstriction. We 
have now identified the TASK-1 channel as an important target for ET-1 at clinically 
relevant concentrations. We have established a role for the TASK-1 channels in the 
ET-1-induced membrane depolarization in primary human PASMCs, using 
TASK-1-siRNA. This might represent an important pathway explaining a part of the 
vasoconstrictive and proliferative properties of ET-1. In addition, these findings might be 
further supported using the isolated perfused mouse lung model, in which the effect of 
anandamide on ET-1-induced pulmonary vasoconstriction was investigated. When 
anandamide was given prior to ET-1, the vasoconstrictive response was augmented. 
This suggests that anandamide and ET-1 have an additive effect on the TASK-1 
inhibition. However, it has to be taken into account that the endocannabinoid 
anandamide, besides TASK-1, also acts on specific cannabinoid (CB1) and on vanilloid 
receptors (VR1). Furthermore, in the mouse model, the expression of other possible 
anandamide-sensitive two-pore domain channels has not been fully characterized until 
now.  
ET-1 has been shown to affect several different types of ion channels in vascular 
smooth muscle cells. Various signaling pathways have been implicated in these effects. 
In our study, we have specifically examined the signaling pathway involved in the 
ET-1-induced TASK-1 inhibition in primary human PASMCs. We have found that 
antagonists of the G protein-coupled-receptor ETA fully abolish the TASK-1 inhibition in 
response to ET-1. The molecular basis of the K+ channel inhibition by an agonist that 
acts on the Gq-coupled receptor upstream of PKC is reasonably well defined for some 
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K+ channels (Suh et al., 2004),(Lei et al., 2003) but has been controversially defined for 
background two-pore domain K+ channels (Mathie, 2007) and in particular not 
investigated in native vascular cells yet. Antagonists of PKC but not PKA inhibit the ET-1 
effect on TASK-1, suggesting that PKC mediates the agonist-induced inhibition. These 
results show that the binding of ET-1 to G protein–coupled ETA receptors activates PKC, 
thereby, modulating the ion channels. Our data indicate that ET-1 can stimulate the 
serine or threonine phosphorylation of TASK-1, and are consistent with the detection of 
phosphoserine in TASK-1(O'Kelly et al., 2002), and the presence of consensus serine 
and threonine protein kinase A and C phosphorylation sites in the TASK-1 peptide 
(Duprat et al., 1997). While a tyrosine kinase consensus site is also present in the 
TASK-1 peptide, ET-1 does not effect the tyrosine phosphorylation of TASK-1. 
Several studies have examined the mechanism by which a G-protein coupled receptor 
agonist may inhibit two-pore domain K+ channels via PKC. These studies suggest that 
an agonist-induced inhibition of the two-pore domain K+ channels is due to 
ATP-dependent pathways (Enyeart et al., 2005), by depletion of the phosphatidylinositol 
4,5-bisphosphate (PIP2) levels (Lopes et al., 2005), directly by a direct action of 
diacylglycerol (DAG) and phosphatidic acid that are generated via PLC (Chemin et al., 
2003) or by elevated intracellular Ca2+ levels (Enyeart et al., 2005). Moreover, a very 
recent study proposes a direct interaction of Gαq with TASK-1 in a mammalian 
heterologous expression system (Chen et al., 2006). The results obtained from different 
laboratories suggest the possibility that the two-pore domain channels may be 
modulated not by a single mechanism but via distinct pathways in different cell types. 
We have found that the inhibition of the phospholipase C abolishes the ET-1 effect on 
TASK-1 indicating that PLC is required, as also shown in Xenopus laevis oocytes 
(Czirjak et al., 2001) and in contrast to the report about a mammalian heterologous 
expression system (Talley et al., 2002). Additional evidence comes from the use of 
COS-7 cells expressing TREK-2 and muscarinic receptor M3, in which the same PLC 
inhibitor was applied to prevent acetylcholine induced inhibition of TREK-2 (Kang et al., 
2006). The inhibitory effect of the PIP2 scavenger on TASK-1, observed in this study, 
confirms previously reported results obtained from different two-pore domain K+ 
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channels expressed in Xenopus oocytes (Lopes et al., 2005) and strongly suggests that 
PIP2 hydrolysis by PLC indeed affects the channel activity. Moreover, we have showed 
that the downstream product of the PIP2 hydrolysis, DAG, underlies the agonist-induced 
inhibition of TASK-1 in hPASMCs. These results are further supported by our 
experiments showing that the DAG-kinase inhibitors abolish the ET-1 effect on TASK-1.
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9. Conclusion and outlook 
 
We demonstrate that TASK-1, a member of the 2-PK channel superfamily is expressed 
in human primary PASMC. TASK-1 controls the resting membrane potential, thus, 
implicating the TASK-1 channels in the regulation of the pulmonary vascular 
tone.TASK-1 might be also the perfect candidate for the initiation of hypoxia–induced 
depolarization in PASMC. Moreover, the TASK-1 modulation by the Gαq pathway is 
achieved by signaling rather than direct interaction between PIP2 and TASK-1 in primary 
human PASMCs (Lopes et al., 2005)(Figure 19). Additionaly, we report here the 
involvement of the background two-pore domain K+ channel TASK-1 in the 
endothelin-1-mediated depolarization in native human PASMC. It is tempting to 
hypothesize that the inhibition of the voltage-independent TASK-1 channel by 
endothelin in human PASMCs contributes to the development of human pulmonary 
hypertension. 
During the last decade, important breakthroughs about the role of the K2P channel family 
in the cardiopulmonary vascular system emerged. Now there exist a clear evidence for 
two pore-domain potassium channels in the heart and lung. They are likely to contribute 
to cardiopulmonary function through their regulation by stretch, hypoxia, pH, 
prostacyclin analogs (such as iloprost and treprostinil), and neurotransmitters. 
Although numerous other members of the K2P family have been shown to be expressed 
in various parts of the cardiopulmonary vascular system, their physiological importance 
is still obscure, partly due to the lack of pharmacological tools that possess selectivity for 
these channels. Genetic approaches using knockout animals and RNA interference 
technology have provided helpful data and will be invaluable in the future for unraveling 
the physiological functions of the many K2P channels that appear to be expressed in the 
muscle and endothelial cells of the cardiopulmonary vascular system. Our 
understanding of the K2P channels in the cardiopulmonary vascular system is still 
embryonic, but it is clear that these channels are likely to be important in the normal 
physiological regulation of the heart-lung and the arteries as well as in pathological 
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processes. Although the pharmacology of the K2P channels is currently poor, as our 
understanding of the channels improves, new drugs with greater selectivity are likely to 
emerge. The K2P channels in the cardiopulmonary vascular system therefore offer a 
high potential for the future development of therapeutic agents against cardiovascular 
diseases and pulmonary arterial hypertension. 
 
 
 
 
Fig. 19. Schematic presentation of the ET-1 signaling pathway in hPASMCs. (from 
Tang et al.; 2009) 
ET-1 binds to the G protein-coupled-receptor (Gαq) ETA, leading to the protein kinase C 
(PKC)-induced phosphorylation of TASK-1 channels through phospholipase C (PLC), 
phosphatidylinositol 4,5-biphosphate (PIP2) and diacylglycerol (DAG). (+) indicate 
agonist and (-) indicate antagonist effects.
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Summary 
 
The characteristics of the two pore-domain potassium channel and its modulation by 
endothelin-1 (ET-1) were tested by means of the whole-cell patch-clamp technique 
combined with TASK-1 small interfering RNA (siRNA) in primary human pulmonary 
arterial smooth muscle cells. We have found that the TASK-1 protein is present in 
primary hPASMC via immunofluorescence and immunoprecipitation methods. PCR 
studies detect only TASK-1 mRNA in primary and cultured hPASMC. 
Under whole cell voltage-clamp conditions, noninactivating K+ current is clearly but 
reversibly inhibited by anandamide, which is a direct and selective TASK-1 channel 
blocker. Its inhibition induces a significant membrane depolarization. As a consequence 
of the inhibition of the outward current, anandamide also influences the reversal 
potential of the current. The anandamide sensitive current is reversed close to -84 mV, 
the calculated Nernst equilibrium potential for K+ under these conditions. Moreover, 
under symmetrical K+ conditions in the same cell, anandamide causes a clear inhibition 
of the K+ current. The anandamide sensitive current is linear and reversed at or near 0 
mV, the calculated Nernst equilibrium potential for K+ under these conditions. We have 
found that the TASK-1 channels are their extreme sensitive to variations in the 
extracellular pH. It behaves in a pH dependent manner in primary hPASMC across the 
full voltage range. A pH of 8.3 significantly hyperpolarizes the cells, whereas 
acidification causes a membrane depolarization in primary hPASMC (-10±1 mV versus 
13±2 mV; n=5).  
By assessing the O2 sensitivity of this channel in primary hPASMC, under current-clamp 
conditions, we have found that hypoxia causes a marked cell depolarization (by 10±1 
mV; n=9) and that the hypoxia-sensitive current reverses close to -84 mV.  
Further investigations, using the TASK-1 small interfering RNA (siRNA) technique show 
that TASK-1 knockdown causes a depolarization of the resting membrane potential 
compared to control cells (-26±1 mV versus -40±2 mV; P<0.05). Pretreatment of 
hPASMC with TASK-1 siRNA results in a lack of significant further suppression of the 
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IKN by anandamide, acidosis, hypoxia, or ET-1.  
In order to detect the modulation by ET-1, we have found that ET-1 markedly reduces 
the TASK-1 current in primary hPASMCs and significantly and dose-dependently 
depolarizes hPASMCs. The concentration-response curve calculation shows that IC50 is 
1.6 ± 0.3 nM (n = 5). The effect of ET-1 on the TASK-1 current is completely abolished 
by a pre-application of 10 μM anandamide or a pH of 6.3. The ET-1-sensitive current is 
reversed close to -84 mV, the calculated Nernst equilibrium potential for K+ under these 
conditions. Application of isoflurane (1mM) enhances the TASK-1 current, and this 
facilitation is blocked by ET-1.  
In order to investigate the possible physiological relevance of TASK-1 for the ET-1 
induced pulmonary vasoconstriction, the ET-1-induced pressor response in the isolated 
perfused mouse lungs was carried out. ET-1 induces a dose-dependent increase in the 
PA pressure. The PA vasoconstriction is more pronounced when anandamide is given 
prior to ET-1. The application of 8 nM ET-1 increases PAP with 15.6 ± 2.3 mmHg. When 
anandamide is given prior to ET-1, the increase is 23.8 ± 1.0 mmHg (n =5). 
To investigate the possible involvement of the ET-1-mediated signal transduction in 
human PASMCs, we have employed different signaling molecular blockers and 
demonstrated that the endothelin-sensitivity of TASK-1 requires ETA receptors, 
phospholipase C (PLC), phosphatidylinositol 4,5-biphosphate (PIP2), diacylglycerol 
(DAG) and protein kinase C (PKC) in hPASMCs. However, caveolins are not involved in 
this process. Additionally, ET-1 stimulates the threonine phosphorylation of TASK-1, but 
not its tyrosine phosphorylation. 
Our results suggest that TASK-1 is expressed in human PASMC and is 
hypoxia-sensitive. Furthermore, TASK-1 is regulated by ET-1 involved in 
ETA-PLC-PIP2-DAG-PKC pathway at clinically relevant concentrations, which might 
represent a novel pathological mechanism related to pulmonary arterial hypertension. 
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Zusammenfassung 
 
In dieser Arbeit wurden die Effekte von Endothelin-1 (ET-1) am two-pore domain 
Kaliumkanal TASK-1 von humanen primären pulmonalarteriellen glatten Muskelzellen 
(PASMCs) geprüft. Für die Untersuchungen wurde die Patch-Clamp Methode mit der 
small interfering RNA Methode kombiniert.   
Mittels pharmakologischen Tools wurde der TASK-1 Kaliumkanal, der auch als 
Hintergrundkaliumkanal bezeichnet wird, in der Ganzzell-Konfiguration der 
Patch-Clamp Methode untersucht. Der nicht-inaktivierende Kaliumstrom des TASK-1 
Kanals wurde durch Anandamide (spezifischer Blocker von TASK-1), durch 
extrazelluläre Azidose und durch Hypoxie inhibiert. Die Anwendung der small interfering 
RNA gegen TASK-1 führte zu einer Inhibierung des TASK-1 Stromes und zu einem 
Verlust der Effekte von Anandamide, Azidose und Hypoxie sowie zu einer signifikanten 
Depolarisation des Membranpotentials der humanen PASMCs (-26±1 mV vs. -40±2 mV; 
P<0.05). Die Existenz von TASK-1 wurde auch mittels PCR und Immunhistochemie 
bestätigt.  
Der sehr effektive Vasokonstriktor Endothelin-1 blockierte den TASK-1 Kanal in klinisch 
relevanten Konzentrationen signifikant. Der Effekt war dosisabhängig mit einer 
halb-maximalen Konzentration (IC50) von 1.6 ± 0.3 nM. Die Effekte von ET-1 am 
TASK-1 Kanal wurden durch Vorapplikation von Anadamide oder Azidose aufgehoben. 
Die Anwendung von ET-1 führte zu einer signifikanten Vasokonstriktion in den 
Pulmonalarterien in der isoliert-perfundierten Mauslunge.  
Weitere Untersuchungen zeigten, dass für die Effekte von ET-1 der Endothelinrezeptor 
A, die Aktivierung von Phospholipase C (PLC), Phosphatidylinositol 4,5-biphosphate 
(PIP2), Diacylglycerol (DAG) und Proteinkinase C (PKC) in humanen PASMCs 
essentiell sind.  
Diese Ergebnisse zeigen, dass TASK-1 für die Effekte von ET-1 eine zentrale 
Bedeutung hat und daher einen neuen Signalweg repräsentiert, der für die Entstehung 
der pulmonalen Hypertonie, aber auch für mögliche therapeutische Ansätze  eine 
wichtige Rolle spielen könnte.
                          ACKNOWLEDGMENTS                PAGE 85
 
Acknowledgments 
 
I would like to extend my sincere gratitude to 
my supervisor, Prof. Andrea Olschewski, 
for her instructive advice and useful suggestions about my thesis,  
and her help in the completion of this thesis; 
 
to Prof. Dr. Horst Olschewski  
for his professional consultation, support and 
indefatigable care for my experimental work; 
 
 
Prof. Dr. Norbert Weissmann and Dr. Rory E. Morty 
for their help and support;  
 
 
Colleagues from the team: Yingji Li, Chandran Nagaraj and Zoltán Bálint 
 for their consultations and support; 
 
Brigitte Agari, Sabine Gräf-Höchst, 
Christiane Hild, Maria M. Stein, 
Alexandra Hof, Maria Schloffer, 
Karin Quanz and Elisabeth Wirnsperger 
for their excellent technical assistance; 
 
 
All the other tutors and teachers 
for their direct and indirect help.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Der Lebenslauf wurde aus der elektronischen 
Version der Arbeit entfernt. 
 
 
 
 
The curriculum vitae was removed from the 
electronic version of the paper. 
